Menu
Question:
What are criteria points for coverage regarding intravenous immune globulin (IVIG) under the Medicare Prescription Drug, Improvement, and Modernization Act?
Answer:
IVIG is covered under this benefit when the patient is diagnosed with a primary immune deficiency disease, it is administered in the home of a patient with a diagnosed primary immune deficiency disease, and the physician determines that home administration of the derivative is medically appropriate. The benefit does not include coverage for items or services related to the administration of the derivative.
CPT® copyright 2021 American Medical Association (AMA). All rights reserved.
Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
CPT is a registered trademark of the American Medical Association.
Subscribe to receive our News, Insights, and Compliance Question of the Week delivered right to your inbox.
Address: 445 Minnesota Street, Suite 514
St. Paul, MN 55101
Phone: (800) 252-1578
Email: support@medlearnmedia.com
Hours: 9am – 5pm CT
Copyright © 2022 MedLearn Publishing. Powered by MedLearn Media.
